Buy & Sell Seagate Technology Holdings PLC (STX) – Seagate Technology Holdings PLC Price Today
Aura AI Summary
Key Stats
- $178.37BMarket Cap
- TechnologySector
- -16.61%3M Drawdown
- $181.40BEnterprise Value
- 0.37%Dividend Yield
- 32 daysTypical Hold Time
Seagate Technology Holdings PLC (STX) is currently valued at a market capitalization of $178.37B, with an enterprise value of $181.40B. Over the past 52 weeks, Seagate Technology Holdings PLC has traded between a low of $104.43 and a high of $834.01, highlighting its annual price range. Over the past three months, Seagate Technology Holdings PLC has recorded a drawdown of -16.61%, reflecting recent price volatility. Seagate Technology Holdings PLC offers a dividend yield of 0.37%, with the most recent dividend of $0.74 paid on 25 Mar 26. On average, investors hold Seagate Technology Holdings PLC for approximately 32 days, indicating typical investor behavior on the platform.
About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Most Recent News
SuperCom wins new electronic monitoring contract in Nevada, expanding to 17 U.S. states since mid-2024.
SuperCom secured a new electronic monitoring contract in Nevada, marking its entry into the state and expanding its U.S. presence to 17 states since mid-2024. The contract involves deploying SuperCom's PureOne GPS technology for offender supervision,...
IREN acquires Awaken to boost global brand and marketing strategy amid expansion.
IREN Limited has acquired Awaken, a creative and media agency, to strengthen its brand awareness and marketing as it expands globally. Awaken, previously IREN's external marketing partner, will now operate in-house with key team members, including CE...
Sitryx Therapeutics to present at major healthcare investor conferences in June 2026
Sitryx Therapeutics, a clinical-stage biopharmaceutical company focused on autoimmune and inflammatory diseases, announced its management will participate in three key investor conferences in June 2026: Jefferies Global Healthcare Conference in New Y...